Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva announces additional regulatory exclusivity for TREANDA
Teva announces additional regulatory exclusivity for TREANDA
Teva announces additional regulatory exclusivity for TREANDA
Submitted by
admin
on November 27, 2013 - 8:41am
Source:
The Fly on the Wall
News Tags:
Teva
Treanda
rituximab
indolent non-Hodgkin's lymphoma
Headline:
Teva announces additional regulatory exclusivity for TREANDA
Do Not Allow Advertisers to Use My Personal information
